Publications

Hoff FW, Huang Y, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Baer MR, Duong VH, Blum WG, Arellano ML, Stock W, Odenike O, Zeidner JF, Olin RL, Smith CC, Schiller GJ, Curran EK, Handa SV, Heerema NA, Chen T, Martycz M, Stefanos M, Marcus SG, Rosenberg L, Druker BJ, Levine RL, Burd A, Yocum AO, Borate UM, Mims AS, Byrd JC, Madanat YF. IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy. Haematologica. 2025. PMID: 41195510

Singal AG, Garcia-Reyes K, Kelley RK, Kim E. Impact of LEAP-012 and EMERALD-1 in the management of HCC. JHEP reports : innovation in hepatology. 2025. PMID: 41503570

Li H, Melnyk JE, Fu BXH, Shrestha R, Zhang M, Sjöström M, Feng S, Anderson JA, Han W, Chesner LN, Shin HJ, Farsh T, Suarez HJ, Nath S, Chou J, Das R, Egusa EA, Calvert M, Kishishita A, Barpanda A, Zhu J, Maheshwari A, Chen WS, Alshalalfa M, Winters A, Hua JT, Liu T, Davicioni E, Wiita AP, Stohr BA, Siddiqui J, Huang B, Small EJ, Shokat KM, Nelson PS, Quigley DA, Wasmuth EV, Gilbert LA, Feng FY. Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer. Nature genetics. 2025. PMID: 41193657

Ho C, Kennedy N, Di M, Gopal AK, Lynch RC, Ng K, Wu QV, Poh C, Raghunathan V, Rasmussen H, Shadman M, Till BG, Ujjani CS, Smith SD. Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma. Clinical lymphoma, myeloma & leukemia. 2025. PMID: 41285650

Chen WS, Tuchayi AM, Sabbagh A, Kim I, Porter E, Ashraf-Ganjouei A, Li YR, Witztum A, Rajagopal A, Seyedin SN, Juarez R, Carroll PR, Feng FY, Small EJ, Hope TA, Hong JC. Utility of metastasis-directed radiotherapy with and without hormonal therapy in management of oligometastatic prostate cancer. JNCI cancer spectrum. 2025. PMID: 41063390

Khartchenko AF, Lam T, Goldhammer N, Bont M, Warhadpande S, Rosenbluth JM, Herr AE. EpiBlot: Joint Mapping of Chromatin Accessibility and Targeted Proteomics in HER2-expressing Breast Cancer Systems. bioRxiv : the preprint server for biology. 2025. PMID: 41040387

de Mestier L, Halfdanarson TR, Apostolidis L, Koumarianou A, Hernando J, Riechelmann R, Bergsland EK, Cingarlini S, Shaheen S, Crona J, Kreutzfeldt S, Mosalem O, Al-Toubah T, Cros J, Strosberg JR. Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy. Endocrine pathology. 2025. PMID: 41182464

Derry-Vick H, Shah NJ, Ahn J, DeAgresta B, Della Pia A, Zaemes JP, Pascual L, Arias-Orozco N, Zemel R, Sidarous G, Serzan M, Lev-Ari S, Alaoui A, Marki A, Nguyen K, Charalampous C, Rahman I, Wilkins O, Girgis M, Sridhar A, Adams D, Pecora AL, Atkins MB, Ip A. Associations Between Anxiety or Depression Diagnosis and Immune Checkpoint Inhibitor Outcomes. Cancer medicine. 2025. PMID: 41176702

Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Bailey J, Burstein HJ, Chen N, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch AM, Lyons J, McCloskey S, McShane M, Mortimer J, Patel SA, Rosenberger LH, Rugo HS, Santa-Maria CA, Schneider BP, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Wei M, Wisinski KB, Yellala A, Yeung KT, Young JS, Schonfeld R, Kumar R. NCCN Guidelines® Insights: Breast Cancer, Version 5.2025. Journal of the National Comprehensive Cancer Network : JNCCN. 2025. PMID: 41213254

Ye J, Goldhammer N, Vohra P, Warhadpande S, de Castro GC, Rodas CKM, Moasser MM, Ramalingam K, Abe SE, Alvarado M, Ewing C, Goodwin KM, Mukhtar RA, Wong JM, Esserman LJ, Balassanian R, Rosenbluth JM. FNA biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling ductal carcinoma in situ. Cancer cytopathology. 2025. PMID: 41066221

Greenland NY, Cowan JE, Ding CC, Sirohi D, Cooperberg MR, Carroll PR, Simko JP, Stohr BA, Zhang L, Chan E. Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrence. Histopathology. 2025. PMID: 41171098

Tsang ES, Shi Q, Olive K, Collisson E, Dixon JG, Cusnir M, Winograd R, Botta GP, Wadlow R, Shergill A, Meyerhardt JA, O'Reilly EM, Ko AH. Alliance A022106: A Phase II/III Trial of Nab-Paclitaxel and Gemcitabine ± Cisplatin as Second-Line Treatment for BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM). JCO Oncology Advances. 2025. PMID: 42610096

Frazer K, Vijayaraghavan M. Syndemic lives of women who smoke and experience homelessness: secondary analysis of US qualitative data. Health promotion international. 2025. PMID: 41433202

Hines MR, Knight TE, McNerney KO, Leick MB, Jain T, Ahmed S, Frigault MJ, Hill JA, Jain MD, Johnson WT, Lin Y, Mahadeo KM, Maron GM, Marsh RA, Neelapu SS, Nikiforow S, Ombrello AK, Shah NN, Talleur AC, Turicek D, Vatsayan A, Wong SW, Maus MV, Komanduri KV, Berliner N, Henter JI, Perales MA, Frey NV, Teachey DT, Frank MJ, Shah NN. Erratum to <Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome><[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>. Transplantation and cellular therapy. 2025. PMID: 41067707

Lai TYY, Arias L, Cheung CMG, Couturier A, Liu W, O'Leary OE, Rafijah N, Shah N, Yoon YH, Patel S, POYANG Study investigators. POYANG: A phase III randomized clinical trial of faricimab for choroidal neovascularization secondary to pathologic myopia: study design and rationale. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2025. PMID: 41152620

Fergus KB, Newberg J, Greenstein R, Fejerman L, Carvajal-Carmona L, Collisson E, Dixit N, Frampton G, Huang FW, Neuhausen SL, Ziv E. Association between ancestry and tumor somatic mutations in a large national cohort of women with breast cancer. NPJ breast cancer. 2025. PMID: 41162424

Wang H, Ge Y, Shao W, Xiong X, Li G, Li N, Hu X, Chen G, Dong K, Ai W, Yu Z, Zheng Z, Wang C, Yao F, Cao X, Li S, Zhao J, Ke W, Tao C, Hou Y, Petrozza A, Fang G. Yttrium oxide engineered substrate enables improved durability for perovskite solar cells. Nature communications. 2025. PMID: 41152230

Krasnow NA, Jayaraj M, Salans M, Kuwahara K, Zhou MH, Fisch S, Boreta L, Braunstein SE, Aghi MK, Batra-Sharma H, Majure M, Chien J, Rugo HS, Morshed RA, Vasudevan HN, Melisko ME, Huppert LA. Evaluating survival trends over time in patients with metastatic breast cancer and brain metastases: a single center retrospective cohort study. Breast cancer research : BCR. 2025. PMID: 41153023

Smith CC, Zwerner IM, Gudjonsson JE, Ward NL. Reevaluating the Imiquimod Model: A Barrier to Translational Progress in Psoriasis. The Journal of investigative dermatology. 2025. PMID: 41143763

Reig M, Sanduzzi-Zamparelli M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, Díaz A, Llarch N, Iserte G, Mollà M, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Yanagihara TK, Ayuso C, Torres F, Bruix J. BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update. Journal of hepatology. 2025. PMID: 41151697